• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Up­dat­ed: FDA ex­pects 'time­ly avail­abil­i­ty' of Covid shots as ad­vi­sors up­date for­mu­la rec­om­men­da­tion

Last week
FDA+
Coronavirus

House pass­es Trump tax bill with PBM and or­phan drug re­forms in­clud­ed

Last week
Pharma
Law

FDA chief to sen­a­tors: 3,000+ staff de­par­tures won't de­lay user fee tar­gets

Last week
FDA+

Up­dat­ed: Hinge Health jumped 18% on its first day as the dig­i­tal health IPO mar­ket reawak­ens

Last week
Financing
Deals

Cigna, No­vo of­fer low­er GLP-1 prices to lure pa­tients to brand-name drugs

Last week
Pharma
Health Tech

FDA names act­ing head of in­spec­tions; J&J again ad­vo­cates for tax poli­cies as al­ter­na­tive to tar­iffs

Last week
Manufacturing

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

Last week
Pharma
FDA+

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

Last week
Pharma
Manufacturing

An un­pre­dictable year for health­care

Last week
Health Tech

End­points News is get­ting a new web ad­dress: https://end­points.news

Last week
Publisher's note

Post-Hoc: AI bio needs to heed the over­hyped his­to­ry of CRISPR

Last week
AI

Sam­sung Bi­o­log­ics to sep­a­rate man­u­fac­tur­ing and biosim­i­lar busi­ness­es

Last week
Manufacturing

Self-guid­ed men­tal health apps can im­prove out­comes and low­er costs, re­port finds

Last week
Health Tech

Sanofi makes $470M move for Vig­il's Alzheimer's drug, while an­oth­er as­set re­turns to Am­gen

Last week
Deals
Pharma

FDA ad­comm votes unan­i­mous­ly against Pfiz­er's prostate can­cer drug com­bo

Last week
Pharma
FDA+

Hinge Health is go­ing pub­lic on Thurs­day at a $3B val­u­a­tion

Last week
Financing
Health Tech

FDA asks Covid vac­cine mak­ers to add more my­ocardi­tis da­ta to la­bels

Last week
Pharma
FDA+

FDA an­nounces ef­forts to fa­cil­i­tate drug im­por­ta­tion from Cana­da 

Last week
Pharma
FDA+

Te­va, No­var­tis get fresh warn­ings from FTC over Or­ange Book patent list­ings

Last week
Pharma
Law

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

Last week
People

FDA ad­comm nar­row­ly votes against Uro­Gen’s blad­der can­cer drug, calls for RCTs

Last week
Pharma
FDA+

BioN­Tech in­vests £1B in grow­ing UK foot­print un­der ex­pand­ed pact with gov­ern­ment

Last week
Deals
R&D

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

Last week
Startups
In Focus

Mod­er­na pulls ap­pli­ca­tion for Covid-flu shot; An­oth­er IPO in Hong Kong

Last week
News Briefing
First page Previous page 1234567 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Confirm Profile

Endpoints News